Nuvasive reported $273.51M in Operating Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbott ABT:US USD 8.64B 245M
Abiomed ABMD:US USD 207.93M 3.17M
Atricure ATRC:US USD 93.97M 4.22M
Baxter International BAX:US USD 6.57B 3.18B
Becton, Dickinson and BDX:US USD 4.27B 165M
Boston Scientific BSX:US USD 2.81B 9M
Cardiovascular Systems CSII:US USD 70.58M 1.41M
Cooper Companies COO:US USD 702.8M 5.7M
Dexcom DXCM:US USD 622.1M 2.9M
Edwards Lifesciences EW:US USD 916.6M 2.2M
Hologic HOLX:US USD 812.4M 73.6M
Insulet PODD:US USD 337.9M 11.8M
Integra Lifesciences IART:US USD 321.46M 15.29M
Intuitive Surgical ISRG:US USD 1.16B 34M
Johnson & Johnson JNJ:US USD 17.97B 211M
Medtronic MDT:US USD 6.18B 125M
Merit Medical Systems MMSI:US USD 268.52M 3.2M
Nuvasive NUVA:US USD 273.51M 3.87M
Stryker SYK:US USD 3.67B 50M
Tandem Diabetes Care TNDM:US USD 252.04M 39.54M
Teleflex TFX:US USD 554.34M 15.04M
Zimmer Biomet Holdings Inc ZBH:US USD 1.42B 76.4M